Read + Share
Amedeo Smart
Independent Medical Education
Ghanim H, Batra M, Green K, Hejna J, et al. Dapagliflozin reduces systolic blood pressure and modulates vasoactive factors. Diabetes Obes Metab 2021;23:1614-1623.PMID: 33729664
Email
LinkedIn
Facebook
Twitter
Privacy Policy